Yüklüyor......
Best Practices in Chronic Myeloid Leukemia Monitoring and Management
Optimal use of current therapeutic opportunities for chronic myeloid leukemia patients requires integration of clinical and laboratory monitoring. Assessment of molecular response (MR) by real-time quantitative polymerase chain reaction is the most sensitive way to monitor tyrosine kinase inhibitor...
Kaydedildi:
Yayımlandı: | Oncologist |
---|---|
Asıl Yazarlar: | , , , |
Materyal Türü: | Artigo |
Dil: | Inglês |
Baskı/Yayın Bilgisi: |
AlphaMed Press
2016
|
Konular: | |
Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4861357/ https://ncbi.nlm.nih.gov/pubmed/27032870 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0337 |
Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|